Stem cell therapy for Alzheimer's disease and related disorders: current status and future perspectives

Experimental & Molecular Medicine
Leslie M TongYadong Huang

Abstract

Underlying cognitive declines in Alzheimer's disease (AD) are the result of neuron and neuronal process losses due to a wide range of factors. To date, all efforts to develop therapies that target specific AD-related pathways have failed in late-stage human trials. As a result, an emerging consensus in the field is that treatment of AD patients with currently available drug candidates might come too late, likely as a result of significant neuronal loss in the brain. In this regard, cell-replacement therapies, such as human embryonic stem cell- or induced pluripotent stem cell-derived neural cells, hold potential for treating AD patients. With the advent of stem cell technologies and the ability to transform these cells into different types of central nervous system neurons and glial cells, some success in stem cell therapy has been reported in animal models of AD. However, many more steps remain before stem cell therapies will be clinically feasible for AD and related disorders in humans. In this review, we will discuss current research advances in AD pathogenesis and stem cell technologies; additionally, the potential challenges and strategies for using cell-based therapies for AD and related disorders will be discussed.

References

Jan 14, 1987·Neuroscience Letters·J HardyB Winblad
Mar 20, 1998·Annals of Neurology·V P PrasherA C Butler
Dec 28, 1999·Proceedings of the National Academy of Sciences of the United States of America·K R BalesS M Paul
Mar 1, 2000·Proceedings of the National Academy of Sciences of the United States of America·D M HoltzmanS M Paul
Feb 24, 2001·Naunyn-Schmiedeberg's Archives of Pharmacology·R SeidlG Lubec
Nov 21, 2001·Nature Reviews. Neuroscience·O Marín, J L Rubenstein
Oct 3, 2003·Journal of Neurophysiology·Douglas Nitz, Bruce McNaughton
Jul 6, 2004·Annals of Neurology·Bradford C DickersonReisa A Sperling
Feb 8, 2005·Nature Neuroscience·Kiichi WatanabeYoshiki Sasai
Jan 25, 2006·Neurology·Yadong Huang
Jul 19, 2006·Stem Cells and Development·Y-D KwakK Sugaya
Sep 26, 2006·Neurobiology of Aging·Anne HämäläinenHilkka Soininen
Oct 6, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Kim A CeloneReisa A Sperling
Sep 4, 2007·Progress in Brain Research·David G AmaralPierre Lavenex
Sep 4, 2007·Progress in Brain Research·Robert J MorganIvan Soltesz
Nov 6, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Tritia R YamasakiFrank M LaFerla
May 9, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·William J MeilandtLennart Mucke
Jun 14, 2008·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·Shuliang WuLouis Yuge
Oct 22, 2008·Nature Neuroscience·Rene O Sanchez-MejiaLennart Mucke
Dec 17, 2008·Neuroscience Letters·A G XuanD H Long
Mar 21, 2009·Journal of Neuroscience Research·Seung U Kim, Jean de Vellis
Apr 10, 2009·Proceedings of the National Academy of Sciences of the United States of America·Nicola FilippiniClare E Mackay
May 12, 2009·Current Opinion in Neurobiology·Hideyuki Okano, Sally Temple
Jun 9, 2009·Cell Transplantation·Marcel M DaadiGary K Steinberg
Jun 24, 2009·Learning & Memory·Inbar Brosh, Edi Barkai
Jul 7, 2009·Annual Review of Psychology·Szu-Han Wang, Richard G M Morris
Jul 28, 2009·Proceedings of the National Academy of Sciences of the United States of America·Mathew Blurton-JonesFrank M LaFerla
Aug 15, 2009·Neuron·Jungsu KimDavid M Holtzman
Aug 27, 2009·Proceedings of the National Academy of Sciences of the United States of America·Scott C BarabanArturo Alvarez-Buylla
Sep 12, 2009·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Nancy A DennisRoberto Cabeza
Jan 22, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Malgorzata JasinskaStanislaw Glazewski
Jan 29, 2010·The New England Journal of Medicine·Henry W Querfurth, Frank M LaFerla

❮ Previous
Next ❯

Citations

Apr 12, 2016·Frontiers in Cellular Neuroscience·Guo-Hui HuangDong-Fu Feng
Dec 18, 2016·Cellular and Molecular Neurobiology·Majid GhareghaniAmir Ghanbari
Dec 3, 2016·Psychiatry Investigation·Ji Han LeeHyun Kook Lim
Mar 8, 2018·Immunology·Jodie StephensonSandra Amor
Oct 18, 2018·Physiological Reviews·Peter KaragiannisKenji Osafune
Mar 31, 2017·Journal of Medical Ethics·Tamra LysaghtCameron Stewart
Oct 28, 2019·International Journal of Retina and Vitreous·Fernando H LojudiceRubens Belfort Junior
Aug 16, 2019·Clinical Science·Manuela DicarloMonica Mattioli-Belmonte
May 7, 2020·RNA Biology·Charannya Sozheesvari SubhramanyamQidong Hu
Jan 27, 2016·Reviews in the Neurosciences·Mária CsöbönyeiováL'uboš Danišovič
Apr 25, 2018·Stem Cells International·Kyeong-Ah KwakYoung-Seok Park
Sep 26, 2019·Neural Regeneration Research·Fu-Qiang ZhangLin-Lin Zeng
Dec 12, 2018·Frontiers in Cell and Developmental Biology·Caghan Kizil, Prabesh Bhattarai
Nov 18, 2018·Frontiers in Behavioral Neuroscience·Parul BaliAkshay Anand
Oct 31, 2020·Stroke and Vascular Neurology·Xiaoxia YangXia Meng
Dec 11, 2020·International Journal of Molecular Sciences·Sofia TonioloMasud Husain
Jun 17, 2019·Life Sciences·Forough Chakari-KhiaviMehdi Yousefi

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
lipidation
genetic modification

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Related Papers

Stem Cell Research & Therapy
Akshata A Almad, Nicholas J Maragakis
Frontiers in Bioscience (Landmark Edition)
Vimal SelvarajWenbin Deng
Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics
Arlene Y Chiu, Mahendra Rao
© 2021 Meta ULC. All rights reserved